Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Joohyuk Sohn, Severance Hospital
ClinicalTrials.gov Identifier:
NCT01208480
First received: September 23, 2010
Last updated: April 9, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)